{
    "title": "103_s1429",
    "content": "The Act titled \"Women and AIDS Research Initiative Amendments of 1993\" establishes a program for research on women and AIDS. This includes a new section on research regarding women in the Public Health Service Act. The Secretary will establish a program for biomedical and behavioral research on HIV cases in women, including prevention research. This includes studying HIV transmission, relationship with other STDs, clinical trials on preventing HIV through treating STDs, and measures to prevent virus exposure and transmission. The program established by the Secretary focuses on biomedical and behavioral research on HIV cases in women. This includes developing rapid, inexpensive STD diagnostic tests, affordable therapy for treatable STDs, prevention methods for women, and substance abuse prevention programs. Research also covers symptoms of infection, treatment, and behavioral prevention strategies. The Secretary's program focuses on biomedical and behavioral research on HIV cases in women, including prevention methods and substance abuse prevention programs. Clinical trials under this title ensure gynecological evaluations for female subjects infected with HIV, with appropriate follow-up services and analysis of examination results. The Secretary conducts clinical trials to determine the effectiveness of standard treatments for gynecological conditions arising from HIV infection. Support services, including transportation, child care, medical and mental health services, and addressing domestic violence, are provided for women participating in these trials. The Secretary provides support services for women participating in clinical trials, including addressing domestic violence and training for trial conductors. Additionally, research is conducted on barrier methods for preventing sexually transmitted diseases, prioritizing women's needs. The Secretary prioritizes research needs identified at a National Institutes of Health meeting on topical microbicides in 1993, focusing on early infectious stages, formulation of new preparations, clinical testing, and acceptability studies. Additionally, epidemiological research is conducted to determine risk factors for HIV infection in women, including contraceptive methods and tampon use. The Secretary is conducting a study on the progression of HIV infection in women, known as the Women's Interagency HIV Study. The study aims to include at least 5,000 women with HIV infection and increase the number of study sites. Research focuses on the relationship between HIV infection and tampon use, other STDs, substance abuse, and sexual activity. The Secretary is conducting an 8-year study on HIV infection in women, focusing on CD4 cells and the development of serious illnesses. The study addresses gynecological conditions and other women-specific issues not currently included in CDC surveillance. The term 'human immunodeficiency virus' is defined as the cause of AIDS. Authorization of appropriations is provided for clinical trials. Authorized appropriations for fiscal years 1994-1996: $20,000,000 for subsection (c)(1), $10,000,000 for subsection (c)(2), $10,000,000 for subsection (c)(3), and $15,000,000 for subsection (c)(4) for prevention programs. Authorized appropriations for fiscal years 1994-1996: $30,000,000 for subsection (d)(1), $10,000,000 for subsection (d)(2), and $15,000,000 for subsection (e) for an interagency study."
}